Magnetic resonance imaging of metastatic disease to the brain with gadobenate dimeglumine

Autor:	Maximilian F. Reiser, Isabella Salerio, M. Korves, Gianpaolo Pirovano, J. Ruscalleda, A. La Noce, Alberto Spinazzi, K. Sartor, Danielle Balériaux, Cesare Colosimo, G. Bongartz, G. R. Cherryman, Paul M. Parizel, K. Bohndorf, M. A. Van Buchem, M. W. Bourne, Günther Schneider, Miles A. Kirchin
Jazyk:	angličtina
Rok vydání:	2002
Předmět:	Male medicine.medical_specialty Initial dose Contrast Media Gadolinium Central nervous system disease Lesion Meglumine Organometallic Compounds medicine Humans Radiology Nuclear Medicine and imaging Prospective Studies GADOBENATE DIMEGLUMINE Neuroradiology medicine.diagnostic_test Brain Neoplasms business.industry Cumulative dose Magnetic resonance imaging Middle Aged medicine.disease Magnetic Resonance Imaging Mr imaging Female Neurology (clinical) Radiology Safety medicine.symptom Cardiology and Cardiovascular Medicine business Nuclear medicine
Zdroj:	Neuroradiology
ISSN:	0028-3940
Popis:	Seventy-four patients with one to eight proven intraaxial brain metastases received a total cumulative dose of 0.2 mmol/kg bodyweight gadobenate dimeglumine, administered as sequential injections of 0.05, 0.05 and 0.1 mmol/kg over a 20-min period. MR imaging was performed before the first administration (T2- and T1-weighted sequences) and after each injection of contrast agent (T1-weighted sequences only). Quantitative assessment of images revealed significant (P
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a11e0aeaa84f4ff67795a3933d16959 https://hdl.handle.net/10067/475320151162165141 Zobrazit plný text záznamu Full text from SpringerLink